Patrick Boland, MD, medical oncologist, Gastrointestinal Oncology team, Rutgers Cancer Institute of New Jersey, RWJBarnabas Health, discusses the development of therapeutic strategies targeting KRAS G12C mutations in colorectal cancer (CRC). Watch more at onclive.com.